Synthetic Hormones Market to grow with a CAGR of 12.15% through 2030
Rising Prevalence of Hormonal Disorders and Rising Infertility Rates are the major drivers for the Global Synthetic Hormones Market growth in the forecast period, 2026-2030
According
to TechSci Research report, “Synthetic Hormones Market - Global Industry Size,
Share, Trends, Competition, Opportunity and Forecast, 2030F”, Global Synthetic Hormones
Market has valued at USD 595.65 Million in 2024 and is anticipated to witness
an impressive growth in the forecast period with a CAGR of 12.15% through 2026-2030.
The global aging population is driving a surge in demand for hormone replacement therapies (HRT) to manage age-related hormonal deficiencies. Older adults increasingly rely on synthetic hormones such as estrogen, progesterone, testosterone, and growth hormones, propelling market growth. Simultaneously, the demand for contraceptive solutions is rising, with oral contraceptive pills, hormone-based intrauterine devices (IUDs), and injectables gaining traction. Heightened awareness of family planning and reproductive health, coupled with government and healthcare initiatives promoting contraception, further accelerates market expansion.
Advancements in biotechnology and pharmaceutical research are also transforming the synthetic hormones landscape. Ongoing R&D investments are yielding improved formulations, innovative delivery mechanisms, and enhanced hormone therapies, such as bioidentical hormone therapy (BHT) and nanotechnology-based hormone delivery systems, which are expanding market potential. Beyond human healthcare, synthetic hormones play a crucial role in livestock and agriculture, particularly in animal husbandry. The dairy and meat industries utilize synthetic hormones to enhance growth rates and boost milk production, fueling the demand for bovine growth hormones (BGH) and reproductive hormones for breeding purposes.
Regulatory approvals and supportive healthcare policies are further bolstering market accessibility. Governments and healthcare agencies are facilitating approvals for new synthetic hormone therapies, while insurance coverage, subsidies, and policy support are making treatments more widely available. Alongside these factors, rising consumer awareness and lifestyle shifts are influencing demand. A growing health-conscious population is increasingly turning to hormone therapies for anti-aging, bodybuilding, and performance enhancement, reinforcing market momentum. Also, emerging markets in Asia-Pacific, Latin America, and the Middle East are witnessing rapid healthcare infrastructure development and expanding pharmaceutical industries. Improved affordability and accessibility of synthetic hormone treatments in these regions are unlocking new growth avenues, positioning these markets as key contributors to the sector’s global expansion.
Browse
over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Synthetic Hormones Market”
Global Synthetic Hormones Market segmentation is
based on Product, Route
of Administration, Application, End User, and Region
Based on Application, the Global Synthetic Hormones Market largest share was held by Male Hypogonadism segment and is predicted to continue expanding over the coming years. Male hypogonadism is a medical condition characterized by low levels of testosterone, and it can affect a significant portion of the male population, especially as men age. As a result, there may be a substantial demand for synthetic hormones to treat this condition. The global population is aging, and with age, there is a natural decline in testosterone levels in men. This demographic trend may increase the prevalence of male hypogonadism and drive demand for synthetic hormone therapies. Increased awareness of male hypogonadism among both healthcare providers and patients may lead to more diagnoses and treatments. This can contribute to a larger market share for this segment. Synthetic hormones, such as testosterone replacement therapy, can effectively manage the symptoms of male hypogonadism, including fatigue, low libido, and mood changes. The effectiveness of these treatments may drive demand.
Based on Region, Asia-pacific region to fastest growth in the Global Synthetic
Hormones Market. The Asia-Pacific region is home to a significant portion of
the world's population, including countries like China and India, which have
populations exceeding one billion each. A large and growing population creates
a substantial patient base for healthcare services and pharmaceutical products,
including synthetic hormones. Like many other parts of the world, the
Asia-Pacific region is experiencing demographic shifts, with a rapidly aging
population. As people age, they are more likely to develop hormone-related
disorders and require hormone replacement therapies, driving demand for
synthetic hormones. Many countries in the Asia-Pacific region are investing in
improving their healthcare infrastructure, expanding access to healthcare
services, and enhancing the availability of pharmaceutical products. This
increased access to healthcare contributes to greater diagnosis and treatment
of hormone-related conditions. Urbanization, changing dietary habits, and
sedentary lifestyles have contributed to an increase in lifestyle-related
hormone disorders, such as diabetes and obesity. These factors drive the need
for hormone management and treatment with synthetic hormones.
Some of the major companies
operating in the Global Synthetic
Hormones Market include:
- Acerus Pharmaceuticals Corp.
- American Regent, Inc.
- Anhui Anke Biotechnology (Group) Co. Ltd.
- BioPartners, Inc
- Eli Lilly and Company
- Endo Pharmaceuticals, Inc.
- F. Hoffmann-La Roche Ltd.
- IBSA Institut Biochimique SA
- Lupin Pharmaceuticals, Inc.
- Pfizer, Inc
Download Free Sample Report
Customers can also request 10% free customization on this report.
“Certain areas, particularly in North America, are
projected to exert significant demand for thyroid treatment. The growth in the
competitive landscape and the presence of well-established companies in the
market, committed to enhance the overall wellbeing of people each year, are
expected to contribute to a remarkable growth of the Global Synthetic Hormones Market
in the forecast period," said Mr. Karan Chechi, Research Director of TechSci Research, a research-based Global management consulting firm.
"Synthetic Hormones Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product (Amino Acid Derivatives, Peptide Hormone, Steroid Hormones), by Route of Administration (Intravenous, Nasal, Oral, Suppository, Topical), by Application (Growth Hormone Deficiency, Male Hypogonadism, Menopause, Thyroid Hormone Deficiency), by End User (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by region, and Competition, 2020-2030F", evaluated the future growth potential of
Global Synthetic Hormones Market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
innovative market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Synthetic
Hormones Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com